UNIONDALE, NY, Aug. 19, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (the “Company” or “ProPhase”), a next generation biotech, genomics and consumer products company, today announced ...

UNIONDALE, NY, Sept. 12, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next generation biotech, genomics and consumer products company, today announced ...

ProPhase Labs, a biotech firm exploring a crypto treasury strategy, has placed its three units under Chapter 11 bankruptcy.

UNIONDALE, NY, Sept. 03, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), (the “Company” or “ProPhase”), a next generation biotech, genomics and consumer products company, announced today ...

The public company has been looking for a way to collect on accounts receivables from its work in New York tents.

ProPhase Labs (PRPH) announced that its three COVID-19 testing laboratory companies filed for reorganization under Chapter 11 in United States ...

GAAP EPS loss of $(0.11) beat the analyst estimate of $(0.15) due to tighter cost controls, not revenue growth. Revenue (GAAP) missed expectations significantly, coming in at $1.2 million against a $3 ...

ProPhase Labs develops and markets over-the-counter health supplements and diagnostic tools. Its product lineup includes dietary supplements for consumer health and the BE-Smart™ esophageal cancer ...